Cadila Healthcare Fact Sheet, Cadila Healthcare Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Cadila Healthcare Fact Sheet    (CADIL)


SHOCKING: Ex-Swiss Investment Banker's Lucrative Income Generating Secret


Here is the latest financial fact sheet of Cadila Healthcare. For more details, see the Cadila Healthcare quarterly results and Cadila Healthcare share price and chart. For a sector overview, read our pharmaceuticals sector report.

CADILA HEALTHCARE Price History

Price Rs 472.0
Mkt Cap Rs m 483,205
Vol '000 255.2
P/E X 28.9
P/CF X 25.8
EPS (TTM) Rs 16.3
% ch % 2.0
No. of shares m 1,023.74
% ch week % 12.1
% ch 1-mth % 15.1
% ch 12-mth % 82.8
52 week H/L Rs 463.8/212.7
(As on Dec 4, 2020 03:36:00 PM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

CADILA HEALTHCARE Financials

No. of Mths
Year Ending
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
5-Yr Chart
Click to enlarge
CADILA HEALTHCARE EQUITY SHARE DATA
High Rs454460558432352 
Low Rs305305362306207 
Sales per share (Unadj.) Rs92.191.6116.3128.6139.2 
Earnings per share (Unadj.) Rs19.214.817.918.511.8 
Diluted earnings per shareRs19.214.817.918.511.8 
Cash flow per share (Unadj.) Rs22.018.523.124.418.6 
Dividends per share (Unadj.) Rs3.203.203.503.503.50 
Adj. dividends per shareRs3.203.203.503.503.50 
Dividend yield (eoy) %0.80.80.80.91.3 
Book value per share (Unadj.) Rs55.768.085.4101.5101.4 
Adj. book value per shareRs55.768.085.4101.5101.4 
Shares outstanding (eoy) m1,023.741,023.741,023.741,023.741,023.74 
Bonus/Rights/Conversions  FV5:1---- 
Price / Sales ratio x4.14.24.02.92.0 
Avg P/E ratio x19.825.825.719.923.7 
P/CF ratio (eoy) x17.220.719.915.115.0 
Price / Book Value ratio x6.85.65.43.62.8 
Dividend payout %16.721.619.618.929.8 
Avg Mkt Cap Rs m388,458391,581470,664378,170286,033 
No. of employees `00015.416.911.812.413.4 
Total wages/salary Rs m12,61615,19818,54521,24124,145 
Avg. sales/employee Rs Th6,105.05,563.010,072.710,585.010,632.7 
Avg. wages/employee Rs Th817.0901.71,569.11,707.81,801.2 
Avg. net profit/employee Rs Th1,272.1901.51,547.71,526.5898.5 
CADILA HEALTHCARE INCOME DATA
Net Sales Rs m94,26893,765119,049131,656142,531 
Other income Rs m1,1561,2841,1322,0111,139 
Total revenues Rs m95,42495,049120,181133,667143,670 
Gross profit Rs m23,30519,04428,47529,73124,198 
Depreciation Rs m2,9213,7335,3885,9866,965 
Interest Rs m5284469111,9353,418 
Profit before tax Rs m21,01216,14923,30823,82114,954 
Minority Interest Rs m430338628469288 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m-25-3000 
Tax Rs m1,7741,2895,6445,3033,198 
Profit after tax Rs m19,64315,19518,29218,98712,044 
Gross profit margin %24.720.323.922.617.0 
Effective tax rate %8.48.024.222.321.4 
Net profit margin %20.816.215.414.48.5 
CADILA HEALTHCARE BALANCE SHEET DATA
Current assets Rs m42,80460,22382,00584,98187,154 
Current liabilities Rs m34,61053,05860,72073,42582,694 
Net working cap to sales %8.77.617.98.83.1 
Current ratio x1.21.11.41.21.1 
Inventory Days Days5270737571 
Debtors Days Days68899811094 
Net fixed assets Rs m46,98772,98483,703133,493133,236 
Share capital Rs m1,0241,0241,0241,0241,024 
"Free" reserves Rs m55,96868,57686,421102,839102,733 
Net worth Rs m56,99269,60087,445103,863103,757 
Long term debt Rs m8,96424,68425,55139,49732,146 
Total assets Rs m105,506152,207180,653234,831236,866 
Interest coverage x40.837.226.613.35.4 
Debt to equity ratio x0.20.40.30.40.3 
Sales to assets ratio x0.90.60.70.60.6 
Return on assets %19.110.310.68.96.5 
Return on equity %34.521.820.918.311.6 
Return on capital %33.318.022.018.313.7 
Exports to sales %47.20000 
Imports to sales %6.20000 
Exports (fob) Rs m44,5370000 
Imports (cif) Rs m5,8380000 
Fx inflow Rs m44,88121,28042,68348,40452,752 
Fx outflow Rs m9,06910,87411,24211,59314,504 
Net fx Rs m35,81210,40631,44136,81138,248 
CADILA HEALTHCARE CASH FLOW
From Operations Rs m 18,935 13,117 9,193 12,819 25,054 
From Investments Rs m -8,635 -28,719 -9,737 -42,387 -10,123 
From Financial Activity Rs m -9,348 23,158 515 18,846 -10,942 
Net Cashflow Rs m 991 7,556 -29 -8,109 3,989 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 74.8%
Foreign collaborators 0.0%
Indian inst/Mut Fund 8.3%
FIIs 5.9%
ADR/GDR 0.0%
Free float 11.0%
Shareholders 44,069
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Zydus Tower, Satellite Cross Roads, Ahmedabad - 380 015
E-MAIL upen.shah@zyduscadila.com WEB www.zyduscadila.com
TELEPHONE (079) 2686 8326 FAX (079) 2686 2365
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Sharepro Serv.,416-420, Devnandan Mall, Ellisbridge, Ahmedabad-09
AUDITOR Mukesh M. Shah & Co.
CHM: Pankaj R. Patel (MD) COMP SEC: Upen H. Shah YEAR OF INC: 1995 BSE CODE: 532321 FV (Rs): 5 DIV YIELD (%): 0.7

Read: CADILA HEALTHCARE 2019-20 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   UNICHEM LAB  SUN PHARMA  NEULAND LABS  AJANTA PHARMA  STRIDES PHARMA SCIENCE  

Compare CADILA HEALTHCARE With:   UNICHEM LAB  SUN PHARMA  NEULAND LABS  AJANTA PHARMA  STRIDES PHARMA SCIENCE  

Compare CADILA HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  




Today's Market

5 Reasons Why Indian Share Markets Closed at Record High Today(Closing)

Indian share markets extended gains as the session progressed and ended on a strong note.

Views on news

CADILA HEALTHCARE 2019-20 Annual Report Analysis (Annual Result Update)

Oct 26, 2020 | Updated on Oct 26, 2020

Here's an analysis of the annual report of CADILA HEALTHCARE for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

CADILA HEALTHCARE Announces Quarterly Results (1QFY21); Net Profit Up 49.3% (Quarterly Result Update)

Aug 21, 2020 | Updated on Aug 21, 2020

For the quarter ended June 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 49.3% YoY). Sales on the other hand came in at Rs 36 bn (up 4.1% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY20); Net Profit Down 79.3% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, CADILA HEALTHCARE has posted a net profit of Rs 829 m (down 79.3% YoY). Sales on the other hand came in at Rs 34 bn (up 13.7% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

More Views on News

Most Popular

Not Infosys or Wipro. India's Next Wealth Creators Could Be Drone Stocks (Profit Hunter)

Nov 25, 2020

India's drones directorate signals the next big defence tech multibaggers.

It's Time to Book Profits (Fast Profits Daily)

Nov 27, 2020

In my first video on Equitymaster, I want to introduce you my proprietary greed and fear index. It's telling us to book some profits in the market.

How the New Margins Will Impact You (Fast Profits Daily)

Nov 25, 2020

The new rules on margins will come into effect from 1st December. Are you ready?

Create Wealth for Yourself in India's Drone Revolution (Profit Hunter)

Nov 27, 2020

The Chinese drone market is 14 times that of India's. Billions may flow into Indian drone companies too. Don't miss out on this wealth creating opportunity.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE - DR. DATSONS LABS COMPARISON

COMPARE CADILA HEALTHCARE WITH

MARKET STATS